Health ❯ Medicine

Patient Care

Personalized Medicine Rehabilitation Quality of Life Cancer Treatment Treatment Options Post-Operative Care Treatment Efficacy Cancer Patients Treatment Outcomes Cancer Screening Post-Transplant Care Recovery Transplant Recipient Care Prescription Access Side Effects Treatment Resistance Medication Management Treatment Protocols Medication Adherence Surgery Home Treatment Nutritional Recommendations Cancer Treatment Strategies Counseling Socioeconomic Factors Life Expectancy Symptom Management Patient Experience Risk Reduction Medication Discontinuation Volunteers in Research Case Studies Family Impact Adverse Effects Infections

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

The company aims to file for FDA approval in the first half of 2026.

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

HSF1-Driven Autophagy Found to Undercut Proteasome Drugs in AML, Preclinical Combo Shows Benefit

Regeneron’s Garetosmab Slashes New Bone Lesions in FOP Phase 3, U.S. Filing Planned This Year

Study Links THC in Ovarian Follicles to Lower Rate of Normal Embryos in IVF

Liraglutide Cuts Chronic Migraine Days by More Than Half

Long-Term Desogestrel Use Linked to Slight Rise in Brain Tumor Risk

JM2 Peptide Disrupts Glioblastoma Stem Cells and Slows Tumor Growth in Preclinical Models

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications